The detailed information for PTAB case with proceeding number IPR2016-00002 filed by Par Pharmaceutical, Inc. against Jazz Pharmaceutical, Inc. on Oct 6, 2015. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2016-00002
Filing Date
Oct 6, 2015
Petitioner
Par Pharmaceutical, Inc.
Respondent
Jazz Pharmaceutical, Inc.
Status
Institution Denied
Respondent Application Number
13872997
Respondent Tech Center
1600
Respondent Patent Number
8772306
Institution Decision Date
Apr 12, 2016
Termination Date
Apr 12, 2016

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Decision - Denying Institution of Inter Partes Review

Apr 12, 2016PAPERBOARD

Patent Owner Preliminary Response

Jan 15, 2016PAPERPATENT OWNER

Patent Owner Exhibit List

Jan 15, 2016PAPERPATENT OWNER

Maitre 1997

Jan 15, 2016EXHIBITPATENT OWNER

Knerr 2007

Jan 15, 2016EXHIBITPATENT OWNER

Bernasconi 1992

Jan 15, 2016EXHIBITPATENT OWNER

Löscher 1999

Jan 15, 2016EXHIBITPATENT OWNER

306 Patent File History, Supplemental Amendment and Response filed November 13, 2013

Jan 15, 2016EXHIBITPATENT OWNER

306 Patent File History, Notice of Allowance

Jan 15, 2016EXHIBITPATENT OWNER

Okun 2001

Jan 15, 2016EXHIBITPATENT OWNER

Van der Worp 2010

Jan 15, 2016EXHIBITPATENT OWNER

Equetro November 2012 Package Insert

Jan 15, 2016EXHIBITPATENT OWNER

National Institute of Mental Health, Bipolar Disorder in Adults, 2012

Jan 15, 2016EXHIBITPATENT OWNER

Morantz 2004

Jan 15, 2016EXHIBITPATENT OWNER

Weisler 2006

Jan 15, 2016EXHIBITPATENT OWNER

Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy Volunteers INX-189-005, clinicaltrials.gov, 2012

Jan 15, 2016EXHIBITPATENT OWNER

DDI Study of Etravirine and GSK1265744, clinicaltrials.gov, 2012

Jan 15, 2016EXHIBITPATENT OWNER

ERG, Examination of Clinical Trial Costs and Barriers for Drug Development, 2014

Jan 15, 2016EXHIBITPATENT OWNER

Peterson 2005

Jan 15, 2016EXHIBITPATENT OWNER

Power of Attorney

Oct 27, 2015PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Power of Attorney

Oct 27, 2015PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Related Matters

Oct 27, 2015PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Power of Attorney

Oct 27, 2015PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Par's Updated Mandatory Notices Pursuant to 37 C.F.R. 42.8(A)(3)

Oct 21, 2015PAPERPETITIONER

Notice of Filing Date Accorded to Petition

Oct 16, 2015PAPERBOARD

Power of Attorney

Oct 6, 2015PAPERPETITIONER

Exhibit List

Oct 6, 2015PAPERPETITIONER

PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 8,772,306

Oct 6, 2015PAPERPETITIONER

U.S. Patent No. 8,772,306

Oct 6, 2015EXHIBITPETITIONER

File History for U.S. Patent No. 8,772,306

Oct 6, 2015EXHIBITPETITIONER

Winkelman Declaration

Oct 6, 2015EXHIBITPETITIONER

Winkelman CV

Oct 6, 2015EXHIBITPETITIONER

Xyrem Orange Book Listing

Oct 6, 2015EXHIBITPETITIONER

Xyrem 2005 Prescribing Information

Oct 6, 2015EXHIBITPETITIONER

Depakote 2011 Prescribing Information

Oct 6, 2015EXHIBITPETITIONER

Cagnin

Oct 6, 2015EXHIBITPETITIONER

Waszkielewicz

Oct 6, 2015EXHIBITPETITIONER

Weiss

Oct 6, 2015EXHIBITPETITIONER

FDA Draft Guidance - Drug Interaction Studies

Oct 6, 2015EXHIBITPETITIONER

Vayer 1988

Oct 6, 2015EXHIBITPETITIONER

Shinka

Oct 6, 2015EXHIBITPETITIONER

Hechler

Oct 6, 2015EXHIBITPETITIONER

Kaufman

Oct 6, 2015EXHIBITPETITIONER

77 Fed. Reg. 9,946

Oct 6, 2015EXHIBITPETITIONER

FDA Approval Letter for Xyrem (Nov. 18, 2005)

Oct 6, 2015EXHIBITPETITIONER

FDA Approval Letter for Depakote Label (Oct. 7, 2011)

Oct 6, 2015EXHIBITPETITIONER

Bhattacharya

Oct 6, 2015EXHIBITPETITIONER

Swann

Oct 6, 2015EXHIBITPETITIONER

Scientific Discussion - Sodium Oxybate

Oct 6, 2015EXHIBITPETITIONER

Find medicine - Xyrem - Assessment History

Oct 6, 2015EXHIBITPETITIONER

FDA Approval Letter for Xyrem (Jul. 17, 2002)

Oct 6, 2015EXHIBITPETITIONER

Xyrem 2014 Prescribing Information

Oct 6, 2015EXHIBITPETITIONER

Cipraini

Oct 6, 2015EXHIBITPETITIONER

Bhattacharya (2004)

Oct 6, 2015EXHIBITPETITIONER

Cui

Oct 6, 2015EXHIBITPETITIONER

Eller

Oct 6, 2015EXHIBITPETITIONER

Harvey

Oct 6, 2015EXHIBITPETITIONER

Kaufman 1988

Oct 6, 2015EXHIBITPETITIONER

Kaufman 1987

Oct 6, 2015EXHIBITPETITIONER

Kennedy

Oct 6, 2015EXHIBITPETITIONER

Loscher

Oct 6, 2015EXHIBITPETITIONER

Morris

Oct 6, 2015EXHIBITPETITIONER

Rumigny

Oct 6, 2015EXHIBITPETITIONER

Schep

Oct 6, 2015EXHIBITPETITIONER

Thompson

Oct 6, 2015EXHIBITPETITIONER

van der Laan

Oct 6, 2015EXHIBITPETITIONER

Vayer 1987

Oct 6, 2015EXHIBITPETITIONER

Whittle

Oct 6, 2015EXHIBITPETITIONER